Dr Andi Shane, chief of the division of pediatric infectious diseases at Emory University School of Medicine, said May 11 in a Facebook Live event that the Pfizer-BioNTech vaccine should be available to 12 - to 15-year-olds shortly after the CDC's advisory committee makes its decision.